Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...

A defining metropolis with an ever-growing population of over 12 million people, São Paulo is Brazil’s largest city and capital of the wealthiest state in the country. A mosaic of influences from ...

NASHVILLE, Tenn. -- Racial biases persist in the use of pulse oximetry devices for patients with acute hypoxemic respiratory failure (AHRF) requiring very high levels of oxygen support, a ...

This neo-Gothic cathedral may catch your eye with its enormous spires and you'll hear it referred to by many (similar) names, including Catedral da Sé, Catedral Metropolitana and Catedral da Sé de São ...

The best time to visit São Paulo is from March to May or October to November (the fall and spring shoulder seasons) when the temperatures are comfortable, the city sees less precipitation (and less ...

Versus Systems Inc. provides a business-to-business software platform to drive user engagement through gamification and rewards. The company offers the eXtreme Engagement Online platform, which is ...

Liberia and Sao Tome and Principe will play World Cup qualifying matchday 6 at the National Complex in Monrovia on March 24, 2025. The forthcoming game will be the final one for both teams during this ...

Ashlyn is one of Forbes Home's in-house writers and a former civil engineer-turned content writer with over six years experience. Until recently, Ashlyn focused on creating content for Forbes Home as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos. Cytokinetics has won FDA approval of its ...

The shares of biotechnology firm Cytokinetics are approaching what may be one of the most consequential weeks in the company’s recent timeline. Investor attention is intensely focused on an imminent ...